West Pharmaceutical Services
(WST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 492,700 | 593,400 | 585,900 | 661,800 | 346,200 |
| Depreciation Amortization | 155,400 | 137,300 | 120,600 | 122,300 | 109,100 |
| Income taxes - deferred | -3,500 | 37,500 | -30,800 | -42,900 | -5,800 |
| Accounts receivable | -58,800 | 4,000 | -35,600 | -123,500 | -46,600 |
| Accounts payable and accrued liabilities | 2,900 | 4,400 | -2,800 | 16,800 | 36,600 |
| Other Working Capital | 2,900 | -20,400 | -15,000 | -198,100 | -10,300 |
| Other Operating Activity | 61,800 | 20,300 | 101,700 | 147,600 | 43,300 |
| Operating Cash Flow | $653,400 | $776,500 | $724,000 | $584,000 | $472,500 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -377,000 | -362,000 | -284,600 | -253,400 | -174,400 |
| Net Acquisitions | N/A | N/A | N/A | -2,200 | N/A |
| Other Investing Activity | -1,700 | -6,700 | -3,600 | 2,500 | -5,100 |
| Investing Cash Flow | $-378,700 | $-368,700 | $-288,200 | $-253,100 | $-179,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 164,700 | N/A | N/A | N/A | N/A |
| Debt Repayment | -192,300 | -2,400 | -44,300 | -2,200 | -2,300 |
| Common Stock Issued | 32,700 | 51,000 | 28,200 | 37,100 | 34,700 |
| Common Stock Repurchased | -566,600 | -451,200 | -222,200 | -151,900 | -121,400 |
| Dividend Paid | -59,100 | -57,000 | -54,100 | -51,100 | -48,100 |
| Other Financing Activity | -2,000 | 0 | -1,200 | 0 | 0 |
| Financing Cash Flow | $-622,600 | $-459,600 | $-293,600 | $-168,100 | $-137,100 |
| Exchange Rate Effect | -21,400 | 11,400 | -10,500 | -15,700 | 20,500 |
| Beginning Cash Position | 853,900 | 894,300 | 762,600 | 615,500 | 439,100 |
| End Cash Position | 484,600 | 853,900 | 894,300 | 762,600 | 615,500 |
| Net Cash Flow | $-369,300 | $-40,400 | $131,700 | $147,100 | $176,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 653,400 | 776,500 | 724,000 | 584,000 | 472,500 |
| Capital Expenditure | -377,000 | -362,000 | -284,600 | -253,400 | -174,400 |
| Free Cash Flow | 276,400 | 414,500 | 439,400 | 330,600 | 298,100 |